NO20006293L - Nye benzopyran eller tiobenzopyranderivater - Google Patents

Nye benzopyran eller tiobenzopyranderivater

Info

Publication number
NO20006293L
NO20006293L NO20006293A NO20006293A NO20006293L NO 20006293 L NO20006293 L NO 20006293L NO 20006293 A NO20006293 A NO 20006293A NO 20006293 A NO20006293 A NO 20006293A NO 20006293 L NO20006293 L NO 20006293L
Authority
NO
Norway
Prior art keywords
new benzopyran
thiobenzopyran
derivatives
thiobenzopyran derivatives
benzopyran
Prior art date
Application number
NO20006293A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006293D0 (no
Inventor
Jae Chon Jo
Hyun Suk Lim
Jong Min Kim
Ju Su Kim
Kazumi Morikawa
Yoshitake Kanbe
Myung Hwa Kim
Masahiro Nishimoto
Original Assignee
C & C Res Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C & C Res Lab filed Critical C & C Res Lab
Publication of NO20006293D0 publication Critical patent/NO20006293D0/no
Publication of NO20006293L publication Critical patent/NO20006293L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
NO20006293A 1998-06-13 2000-12-11 Nye benzopyran eller tiobenzopyranderivater NO20006293L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019980022212A KR20000001793A (ko) 1998-06-13 1998-06-13 신규한 벤조피란 또는 티오벤조피란 유도체
PCT/KR1999/000300 WO1999065893A1 (fr) 1998-06-13 1999-06-14 Derives de benzopyran ou de thiobenzopyran

Publications (2)

Publication Number Publication Date
NO20006293D0 NO20006293D0 (no) 2000-12-11
NO20006293L true NO20006293L (no) 2001-02-13

Family

ID=36293964

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006293A NO20006293L (no) 1998-06-13 2000-12-11 Nye benzopyran eller tiobenzopyranderivater

Country Status (12)

Country Link
US (2) US6645951B1 (fr)
EP (1) EP1087959A1 (fr)
JP (1) JP4856310B2 (fr)
KR (2) KR20000001793A (fr)
CN (1) CN1312803A (fr)
AU (1) AU756589B2 (fr)
CA (1) CA2334634A1 (fr)
HU (1) HUP0102466A3 (fr)
IL (1) IL139808A0 (fr)
NO (1) NO20006293L (fr)
RU (1) RU2001101466A (fr)
WO (1) WO1999065893A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ266199A0 (en) * 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
AU1888101A (en) * 1999-12-13 2001-06-18 Chugai Seiyaku Kabushiki Kaisha 3-methyl-chroman and -thiochroman derivatives
WO2001042233A1 (fr) * 1999-12-13 2001-06-14 Chugai Seiyaku Kabushiki Kaisha Derives de chromane et de thiochromane optiquement actifs
JP4798924B2 (ja) * 1999-12-13 2011-10-19 中外製薬株式会社 ヒドロキシカルボニル−ハロゲノアルキル側鎖を有する化合物
EP1241158A4 (fr) 1999-12-13 2004-02-11 Chugai Pharmaceutical Co Ltd Compose a chaine laterale hydroxycarbonyl-halogenoalkyle
WO2001042235A1 (fr) * 1999-12-13 2001-06-14 Chugai Seiyaku Kabushiki Kaisha Derives de 3-ethyl-, 3-propyl-, ou 3-butyl-chromane et -thiochromane
KR20010055766A (ko) * 1999-12-13 2001-07-04 이경하 3-메틸-크로만 또는 티오크로만 유도체의 금속염
KR20010055765A (ko) * 1999-12-13 2001-07-04 이경하 3-메틸-크로만 또는 티오크로만 유도체
PL365062A1 (en) * 2001-01-24 2004-12-27 Chiesi Farmaceutici S.P.A. 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
CN1646119A (zh) * 2002-04-09 2005-07-27 诺沃根研究有限公司 涉及异黄-3-烯和异黄烷结构的治疗方法和组合物
US6963002B2 (en) * 2003-07-04 2005-11-08 Glenmark Pharmaceuticals Limited Process for the preparation of 4,4-dimethyl-6-ethynylthiochroman
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
US7601855B2 (en) 2004-09-21 2009-10-13 Novogen Research Pty Ltd Substituted chroman derivatives, medicaments and use in therapy
EP1809618B1 (fr) * 2004-09-21 2013-07-17 Marshall Edwards, Inc. Dérivés de chromane, médicaments et utilisation à des fins thérapeutiques
ES2516067T3 (es) * 2004-09-21 2014-10-30 Mei Pharma, Inc. Derivados de cromano sustituidos, medicamentos y utilización en terapia
JP4976649B2 (ja) * 2004-09-21 2012-07-18 マーシャル エドワーズ,インク. 化合物
DK2533638T3 (en) * 2010-02-12 2016-04-25 Nivalis Therapeutics Inc NOVEL S-nitrosoglutathione REDUCTASE
DE102010030538A1 (de) * 2010-06-25 2011-12-29 Bayer Schering Pharma Aktiengesellschaft 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
EP2635121B1 (fr) 2010-11-01 2020-01-08 MEI Pharma, Inc. Composés d'isoflavonoïdes et procédés pour le traitement du cancer
EP2487171A1 (fr) * 2011-02-08 2012-08-15 Université de Liège Dérivés de dihydrobenzopyrane, thiochromane, tétrahydroquinoléine et tétrahydronaphthalène et leur utilisation pour la thérapie anti-cancer
DE102011087987A1 (de) 2011-12-08 2013-06-13 Bayer Intellectual Property Gmbh 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
HUE054998T2 (hu) 2015-02-02 2021-10-28 Mei Pharma Inc Kombinációs terápiák emlõrák kezelésében való alkalmazásra
EP3681495A4 (fr) * 2017-09-15 2021-06-02 Nyrada Pty Limited Traitement de l'excitotoxicité
CN109574970A (zh) * 2018-12-27 2019-04-05 上海毕得医药技术有限公司 一种5-溴苯并二氢吡喃的合成方法
US20230167140A1 (en) 2020-04-30 2023-06-01 Shanghai Senhui Medicine Co., Ltd. Inositol derivative and use thereof
CN117924262A (zh) * 2022-10-14 2024-04-26 中国科学院上海药物研究所 二氢苯并噻喃类衍生物及其制备方法和用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1543749A1 (de) * 1966-02-16 1969-12-11 Merck Ag E Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
DE2006505A1 (de) * 1970-02-13 1971-08-26 Merck Patent Gmbh, 6100 Darmstadt Isoflavanoid ather und Verfahren zu ihrer Herstellung
DE2745305A1 (de) * 1977-10-07 1979-04-19 Bayer Ag Insektizide und akarizide mittel
US4801593A (en) * 1979-09-13 1989-01-31 Burroughs Wellcome Co. Chemotherapeutic agents
DE2950135A1 (de) * 1979-12-13 1981-06-19 Merck Patent Gmbh, 6100 Darmstadt Basischer aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
JPS60178815A (ja) 1984-02-24 1985-09-12 Rikagaku Kenkyusho 制癌剤
US6060503A (en) * 1991-12-02 2000-05-09 Endorecherche, Inc. Benzopyran-containing compounds and method for their use
HUT68558A (en) 1993-07-20 1995-06-28 Chinoin Gyogyszer Es Vegyeszet Method for preparing isoflavon derivatives
US5607898A (en) * 1993-08-02 1997-03-04 Idemitsu Kosan Company, Ltd. Pyrazole derivatives
FR2731706B1 (fr) * 1995-03-14 1997-04-11 Cird Galderma Composes heterocycliques aromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
US6043269A (en) * 1996-10-28 2000-03-28 Novo Nordisk A/S cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5985306A (en) * 1996-10-28 1999-11-16 Novo Nordisk A/S (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
US5919817A (en) * 1996-10-28 1999-07-06 Novo Nordisk A/S Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US6316494B1 (en) * 1996-10-28 2001-11-13 Novo Nordisk A/S cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5994390A (en) * 1996-10-28 1999-11-30 Novo Nordisk Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ES2185054T3 (es) * 1996-12-13 2003-04-16 Chugai Pharmaceutical Co Ltd Derivados de benzopirano.
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation
FR2778404B1 (fr) * 1998-05-06 2000-06-30 Hoechst Marion Roussel Inc Derives du dihydro ou tetrahydronaphtalene, et les compositions pharmaceutiques les renfermant
AU4165299A (en) * 1998-06-12 1999-12-30 C & C Research Laboratories Prodrugs of estrogen antagonist
US6680332B1 (en) * 1999-06-04 2004-01-20 Euro-Celtique S.A. Substituted 5-oxo-5,6,7,8-tetrahydro-4H-1-benzopyrans and benzothiopyrans and the use thereof as potentiators of AMPA
US20010046489A1 (en) 1999-12-06 2001-11-29 Habener Joel E. Stem cells of the islets of langerhans and their use in treating diabetes mellitus
IL156595A0 (en) * 2001-01-16 2004-01-04 Astrazeneca Ab Therapeutic heterocyclic compounds
US6916831B2 (en) * 2003-02-24 2005-07-12 The University Of North Carolina At Chapel Hill Flavone acetic acid analogs and methods of use thereof

Also Published As

Publication number Publication date
CN1312803A (zh) 2001-09-12
KR20000001793A (ko) 2000-01-15
CA2334634A1 (fr) 1999-12-23
RU2001101466A (ru) 2004-03-10
HUP0102466A3 (en) 2003-07-28
US20040102479A1 (en) 2004-05-27
AU4171999A (en) 2000-01-05
JP4856310B2 (ja) 2012-01-18
AU756589B2 (en) 2003-01-16
US6645951B1 (en) 2003-11-11
HUP0102466A2 (hu) 2002-01-28
JP2002529372A (ja) 2002-09-10
WO1999065893A1 (fr) 1999-12-23
US7074819B2 (en) 2006-07-11
IL139808A0 (en) 2002-02-10
EP1087959A1 (fr) 2001-04-04
NO20006293D0 (no) 2000-12-11
KR20010052755A (ko) 2001-06-25

Similar Documents

Publication Publication Date Title
NO20006293L (no) Nye benzopyran eller tiobenzopyranderivater
NO983356L (no) Nye 19-nor-pregnenderivater
NO20010193D0 (no) Tiobenzimidazol-derivater
DK0930302T3 (da) Benzosulfonderivater
NO20003346L (no) Nye erytromycinderivater
NO20010514D0 (no) Aminometylkarboksylsyre-derivater
EE200100083A (et) Fenüülksantiini derivaadid
EE200000140A (et) Asendatud kromaani derivaadid
PT1070059E (pt) Derivados de cromanona e tiocromanona
DK1237857T3 (da) Nye Phenalkyloxyphenylderivater
EE200000144A (et) Asendatud kromaani derivaadid
DE69930543D1 (de) Piperazin-derivate
NO20003965D0 (no) Nye dihydroksyheksansyre-derivater
NO20010860D0 (no) Nye forbindelser
NO20010861D0 (no) Nye forbindelser
DE59914471D1 (de) Chromenon- und chromanonderivate als integrinhemmer
ATE224891T1 (de) Chromon-derivate
PT1140890E (pt) Derivados de cromano
DK1115716T3 (da) 2-phenylpyran-4-on-derivater
DK1134219T3 (da) Cucloalkylsubstituerede aminomethylpyrrolidinderivater
DK0931087T3 (da) Nye pyranosidderivater
DK1060183T3 (da) 5-deoxycytidinderivater
NO20015652L (no) 1-trifluorometyl-4-hydroksy-7-piperidinyl- aminometylkromanderivater
ATE273973T1 (de) Benzofuranderivate
NO20010584L (no) Nye forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application